Share “Pfizer to pay $55 million in drug...”

Pfizer to pay $55 million in drug misbranding case

Published on NewsOK Modified: December 12, 2012 at 2:55 pm •  Published: December 12, 2012

WASHINGTON (AP) — The Justice Department says Pfizer Inc. will pay $55 million to resolve allegations that its subsidiary Wyeth LLC promoted the drug Protonix for uses that were not approved by the Food and Drug Administration.

In a written statement from its New York office, Pfizer, which acquired Wyeth in October 2009 years after the alleged misconduct, said that Pfizer was not a target or a subject of the case.

Wyeth obtained FDA approval to promote Protonix only for short-term treatment of erosive esophagitis. The condition is associated with gastro-esophageal reflux disease. Wyeth allegedly promoted Protonix for all forms of GERD from February 2000 to June 2001.

GERD is a condition in which food or liquid leak backwards from the stomach into the esophagus.

Pfizer's statement specifically denied allegations of wrongdoing.


  1. 1
    Former OSU student convicted of manslaughter in 2009 fatal car crash released on bail; attorney...
  2. 2
    Police find dead body in porta-potty outside Cincinnati Bengals' Paul Brown Stadium
  3. 3
    Several Deer Creek schools on lockdown due to report of suspicious person
  4. 4
    Tulsa mother gets three life sentences, father 25 years in 'horrific' child abuse case
  5. 5
    Man who calls police to say he's 'too high,' found in pile of Doritos
+ show more


× Trending business Article